Durham-based Heat Biologics has inked a deal to acquire an 80 percent controlling interest in Pelican Therapeutics Inc., an immuno-oncology company based in Austin, Texas. The deal pays up to $500,000 up front to Pelican shareholders, which also includes stock, milestones, sublicensing, income payments and loans.